Find and Pitch Jounalists, Get Your Story Covered

Tags: gabapentin duloxetine fibromyalgia chronic musculoskeletal pain postherpetic neuralgia

	Profile	Recent Articles on Subject
1	Kristen Monaco MedPage Today	ADHD Drug Recall; Alcohol and Sports Gambling; Deprescribing Benzodiazepines - 29 days ago Clonazepam Recall Expands; Lipid Depression Screening; Period Pain and Depression - 4 months ago MDMA for PTSD Under FDA Review; GLP-1 for Opioid Cravings; ADHD an Evolutionary Aid? - about 1 year ago Another Mid-Stage Psychedelic Win; Gun Suicides Reach High; Magnetic Seizure Therapy - over 1 year ago
2	Frank Vinluan MedCity News Medical innovation tracker. MedCity, USA medicalinnovation	AbbVie Enters Obesity Field, Paying $350M for Amylin Receptor Agonist Already in the Clinic - about 1 month ago Vertex Pharma’s Opioid Alternative Wins FDA Approval, First in a New Class of Pain Meds - 2 months ago Lundbeck’s Neuro-Rare Pipeline Lands Cornerstone Drug via $2.6B Longboard Pharma Acquisition - 6 months ago Takeda Drug Fails Pivotal Tests in 2 Rare Epilepsies; Path Forward Depends on Regulatory Flexibility - 10 months ago
3	Kennedy Ferruggia, Assistant Editor Pharmacy Times #pharmacy news, insights. CE provider. Cranbury, New Jersey pharmacyhealthcarejournalism	Pharmacist's Role in Duloxetine Therapy: Improving Medication Adherence in Older Adults With Depression, Pain - about 2 months ago Posdinemab Receives FDA Fast Track Designation for Treatment of Alzheimer Disease - 3 months ago Researchers Evaluate Pain Management Therapy Intervention to Treat Chronic Postherpetic Neuralgia - 3 months ago FDA Approves Ravulizumab-cwvz for Neuromyelitis Optica Spectrum Disorder - about 1 year ago
4	The Conversation Science Alert Science news. Official account. Australia science news	New Non-Opioid Painkiller First in Decades to Win FDA Approval - about 2 months ago Ozempic vs Supplements: Dietitian Reveals Truth About GLP-1 Imitations - 4 months ago Deaths Linked to a Common Anxiety Drug Have Surged in The UK - about 1 year ago
5	Judy George MedPage Today Medical reporter, writer. Medical reportingartsliterature	Gabapentin May Not Raise the Risk of Falling After All - 3 months ago Continuous Parkinson's Disease Therapy Wins FDA Nod - 6 months ago Nipocalimab Shows Sustained Efficacy in Myasthenia Gravis - 6 months ago Novel Agent Reduces Monthly Migraine Days - 7 months ago Gabapentin for Everything; New Brunswick Brain Mystery; Replacing Bits of Old Brain - 8 months ago Vitamin D-MS Link; Nootropic Gummies Laced With Psilocybin; Forecasting Seizures - 8 months ago ALS Therapy to Be Pulled From the Market, Drugmaker Says - 12 months ago FDA Warns of Rare Life-Threatening Reaction to Anti-Seizure Drugs - over 1 year ago
6	John Gever MedPage Today MedPage Today factotum. Pittsburgh, Pa. Healthcare journalism	Anti-Zoster Drug Prevents Shingles in Lupus Patients on Anifrolumab - 3 months ago Opioid Antagonist Flops as Fibromyalgia Therapy - over 1 year ago
7	Allison DeAngelis STAT News Reporter at STAT. Formerly Insider, BBJ. biopharmastartupsventure capital	STAT+: Axsome to send Alzheimer’s disease drug to FDA, despite mixed Phase 3 results - 3 months ago
8	John Pinching PharmaTimes Next-gen biopharma company. La Jolla, California biopharmadrugsdevices	UK grants promising innovative medicine status to CIDP treatment - 4 months ago IRLAB’s new drug shows promise in treating apathy in Parkinson’s patients - 6 months ago
9	Greg Laub MedPage Today Director of Video at MedPage Today. Screenwriter, previous managing editor. videographyscreenwritingediting	Inebilizumab for Myasthenia Gravis Reduces Steroid Burden - 5 months ago
10	Elaine Chen STAT News Reporter at STATnews. Formerly at Business Insider. Chicago, Illinois journalism	More evidence on GLP-1s and opioid addiction - 6 months ago

Journalists covering gabapentin